Clinical Trial Update: Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Ro 31-8959 plus Zidovudine (AZT) vs AZT plus Zalcitabine (ddC) vs Ro 31-8959 plus AZT plus ddC in HIV infection; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ro 31-8959
• Zalcitabine (ddC) (Zalcitabine)
• Zidovudine (AZT) (Zidovudine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 2 | Status: COMPLETED